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abstract
background: The clinical course of Dengue Hemorrhagic Fever (DHF) is difficult to predict. 
An improvement of platelet count is one of the recovery parameters in DHF patients. Immature 
platelet fraction (IPF) can be used to estimate platelet count changes in the next 1-2 days in DHF 
patients. We analyzed the correlation between immature platelet fraction and platelet count 
changes in DHF patients patients.
Methods: The cross-sectional observational analytical was used in this research. Thirty adult 
DHF patient with were enrolled in this study. IPF and platelet count change of each patient were 
measured. , then correlation analysis between immature platelet fraction and platelet count 
changes in DHF patients was analyzed using Pearson test.
results: There were 30 DHF patients consisting of 18 (60%) male and 12 (40%) female with 
mean age of 24.83 ± 9.18, mean immature platelet fraction 11.77 ± 5.5%, and mean platelet 
count change 29,547 ± 45,244.12 / μl. From Pearson correlation test p <0.001 and r = 0.746 
were obtained, suggesting strong correlation. 
conclusion: There was a strong correlation between IPF and platelet count changes 
in DHF patients. 
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clinical and early laboratory conditions seem to be 
healthy in a short time that may get worsened and 
untreated. Conversely, many DHF patients with 
clinical and laboratory conditions seem to be 
healed and survived the disease (8). Improvement 
of platelet count is one of the recovery parameters 
in DHF patients (1).
Dengue virus infection continues to increase in 
prevalence every year, it is estimated there are 50 
- 100 million cases of Dengue virus infected and 
2.5 billion people in high risk (1). In 2006, there 
was a dengue fever epidemic in India by 12.317 
cases with 184 deaths. In 2010, 2012, 2013 there 
were 28.292, 50.222, and 75.808 cases, respec-
tively.in by. WHO stated that Case Fatality Rate 
has declined from 3.3% in 1996 to 0.4% in 2010 
after the WHO guidance guidelines (1). In 2013, 
approximately 96 million cases of dengue infec-
tions occured each year, this increased more than 
three times compared to the number of cases in 
2012 according to WHO data (9). In 2015, in East 
iNTroducTioN
Clinical manifestations of dengue virus infec-
tion highly vary from asymptomatic, non-specific 
fever, dengue fever to dengue shock syndrome (1, 
2). Thrombocytopenia is one of the simplest crite-
ria of WHO that plays a role as a clinical diagnosis 
of DHF. In DHF patients thrombocytopenia may 
occur due to suppression of platelet production in 
the bone marrow, increased platelet consumption 
caused by disseminated intravascular coagulation, 
platelet destruction caused by increased apoptosis, 
lysis by the complement system and the presence 
of antiplatelet antibodies (3-7). The clinical course 
of DHF disease is difficult to predict, patients with 
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Java, there was an increase in dengue cases by 
46% and 15 districts/cities experienced outbreaks 
as the number of dengue cases in the region dou-
bled compared to the same month in 2014 (10).
In the condition of thrombocytopenia without 
bone marrow disorder, new platelets are more 
widely released from megakaryocyte, larger plate-
lets with high RNA content are called reticulated 
platelets (immature platelets). Immature platelet 
fraction (IPF) is an additional parameter that can 
be monitored to predict the recovery of platelet 
count by measured percentage of immature plate-
let to the total platelet count. The normal values in 
healthy individuals were assigned 1.1 to 6.1% (11). 
IPF was examined using Sysmex hematology ana-
lyzer with the flowcytometry method. Immature 
platelet fraction can be used to estimate platelet 
count recovery time in the next 1-2 days (12).
Several research revealed that IPF had a strong 
relationship with platelet count reconstitution in 
dengue infection patients with evidence that 
93.75% of patients had recovered thrombocytope-
nia within 24-48 hours after IPF increased (13). 
IPF was found higher in dengue hemorrhagic fever 
compared to dengue fever, whereas platelet count 
was lower in dengue hemorrhagic fever than den-
gue fever. IPF of dengue hemorrhagic fever on the 
third day was significantly different from IPF on 
the first day of hospitalization (14).
IPF was higher in patients with lower platelet 
counts (14). Patients with thrombocytopenia where 
IPF ≥6.25 indicated that there was a 67% chance of 
an increase in platelet count by 20,000 within 48 
hours and an IPF ≥10.6 score indicated that there 
was a 100% chance of platelet increase by 20,000 
within 48 hours (15). If we know the correlation 
between immature platelet fraction with platelet 
count change then we can use IPF for monitoring 
the change of platelet count in DHF patients. 
Therefore, we wanted to know the correlation be-
tween immature platelet fraction and platelet count 
change in dengue hemorrhagic patients.
meThods
This study was an analytical observational with 
cross-sectionaldesign. Inpatient patients in the 
Tropic-Infectious Disease Room of Internal Medi-
cine in Dr.Soetomo Teaching Hospital Surabaya 
diagnosed with DHF according to WHO SEARO 
2011 criteria that met inclusion but not exclusion 
criteria were the subjects of this study.and does 
meet. The inclusion criteria were as follows: pa-
tients with DHF based on WHO 2011, fever lasted 
less than 6 days, aged 17-60, approved to partici-
pate in this study by signing an informed consent. 
Subjects suffering from other medical disorders 
that cause thrombocytopenia (leukemia, aplastic 
anemia, SLE, SH, ITP) was exclusion criteria. 
Subjects were selected by consecutive sampling 
until the sample size requirement was fulfilled. 
The subjects filled informed consent, underwent 
anamnesis, physical and laboratory examination, 
venous blood sampling by 3 ml for platelet fraction 
examination, and measurement immature platelet 
fraction at 4/5th day fever. Immature platelet frac-
tion was examined at Pramita Pramita Hospital Lab-
oratory, with repeated thrombocyte measurement in 
the next two days on at 6/7th day fever. Immature 
platelet fraction was examined using Sysmex auto-
analyzer haematology and expressed in % unit. Data 
of platelet count change and immature platelet frac-
tion were recorded and analyzed..
The data were analyzed with descriptive statis-
tics and presented in the form of frequency distri-
bution tables and diagrams. The correlation be-
tween immature platelet fraction and platelet count 
change were analyzed using Pearson correlation 
test if data were normally distributed, or using 
Spearman’s test if the data distribution were not 
normal.. Interpretation of correlation test was de-
termined based on p-value, correlation strength, 
and direction of correlation.
resulTs
In this study 30 adult patients diagnosed with 
DHF based on serology NS1 or positive IgM Den-
gue were enrolled,  with the youngest patient aged 
17 and the oldest aged 50. The highest proportion 
of study subjects was found in the age group of 
17-27 years. The general characteristics of sub-
jects in this study are shown in table 1.
From the results of IPF examination on 30 sub-
jects of DHF research it was obtained that the data 
distribution based on the Shapiro-Wilk normality 
test was normal with an average of 11.77 ± 5.5%. 
From the platelet count examination on the 4th/5th 
day of fever  it was obtained that the data distribu-
tion based on the Shapiro-Wilk normality test was 
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abnormal, with mean of 36.677.33 ± 25.318.95 (/ μl), 
median 28.465 (/ μl) and minimum value 3.000 (/ 
μl) and a maximum value of 92.140 (/ μl). While 
the results of the 6th / 7th platelet count of the heat 
of the study subjects based on Shapiro-Wilk nor-
mality test had normal distribution, with mean of 
66.224.33 ± 38.525.27 (/ μl), median 72.440 (/ μl) 
and minimum value 11.360 (/ μl ) and a maximum 
value of 157.300 (/ μl).
The change of platelet count of study subjects 
after analyzed using paired t-test showed significant 
difference with p = 0,001 (significant when p <0,05), 
meaning that there was the significant difference in 
platelet count of research subjects. Based on the re-
sult of thrombocyte count examination on 30 sub-
jects of DHF distribution the value of platelet count 
change from the Shapiro-Wilk normality test 
showed normal distribution, with mean value of 
platelet count change of 29.547 + 45.244,12 / μl, 
median 24.105 (/ μl) and minimum value -75.930 (/ 
μl) and a maximum value of 142.890 (/ μl).
In the data normality test, Shapiro-Wilk con-
cluded that the data spread normally if the value of 
p-value obtained was greater than the significance 
level of 5% (> 5%). The result of normality test of 
data to IPF and platelet count change was obtained 
p-value value of 0.976 and 0.314,  suggesting that 
distribution of IPF distribution and platelet count 
change were normal. 
Based on the result of the IPF data and normal 
platelet count change, then to analyze the correla-
tion between IPF and platelet count change is used 
the parametric correlation of Pearson. Conditions 
used is a correlation can be concluded meaningful 
if the value of p-value obtained is smaller than 5% 
significance level (<5%). Results of analysis of the 
relationship between IPF and platelet count change 
in this study by using Pearson correlation analysis 
obtained Pearson r value of 0.746 with p-value 
0.000. The value of r was 0.746 which showed a 
strong correlation. IPF relationship with platelet 
count change in this study waspositive or a mean-
ingful direction with increasing levels of IPF then 
platelet count changes will increase.
discussioN
This study followed 30 DHF patients mostly 
male, with the ratio of 1.5: 1. The subjects in this 
study had an average age of 24.83 years, the young-
est patient was 17 years old, while the oldest pa-
tient was 50 years old, almost the same as the pre-
vious research, the mean age of 27.23 years with 
the age range between 14 -54 (14).
The sample of this research was 30 dengue fever 
patients with the first degree of dengue fever by 10 
(33,33%), DHF II patients were 16 (53,33%), DHF 
III patients was 4 (13,33%) and no patient DBD de-
gree IV. Serologic diagnosis with NS1 + by 15 pa-
tients (50%) and IgM + by 15 patients (50%). In this 
study, serologic examination for diagnosis of DHF 
was performed NS1 in patients who came with 1st 
-4th day of fever, while patients who came with the 
5th -day of were examined the IgM Dengue.
From the examination of platelet count on the 
4th/5th day of fever in this study, the distribution 
was found to be abnormal, with a median of 28.465 
/μl and a minimum value of 3.000 /μl and a maxi-
mum value of 92.140 /μl. This result was different 
from examining platelets of DHF patients on the 
first day of admission who received platelet mean 
of 77.250 ± 38.041 /μl (14). While the result of 
thrombocyte count of the 6th/7th day of heat has a 
normal distribution with a mean of 66.244.33 ± 
38.525.27 /μl. This result way different from the 
study examining the platelet count of DHF patients 
on the 3rd day of admission to the hospital who 
received platelet mean of 94.150 ± 62.116 /μl (14).
In this study, the result of IPF examination, 
based on Shapiro-Wilk normality test was normal 
with the mean of 11.77 ± 5.5%. This result was dif-
ferent from the study that examined the IPF in 20 
DHF patients on the first day of admission who re-
ceived an average IPF of 4.65 ± 3.87% (14).
In this research, the result of IPF average higher 
TAbel 1 
General Characteristics of Patients
General 
Characteristics
Results
Sex Male 18 (60%)
Female 12 (40%)
Age (year) Rerata ± SD 24,83 ± 9.18
Serology Test NS 1+ 15 (50%)
Ig M+ 15 (50%)
Degrees of DHF I 10 (33,33%)
II 16 (53,33%)
III 4 (13,33%)
IV 0
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than another research result. This was because the 
mean of platelet count in the patient of this re-
search sample was lower. The lower the platelet 
count in dengue patients the patient’s IPF score 
will be higher during the recovery phase in the 
course of DHF as a compensation for the condition 
of thrombocytopenia occurring.
Based on the result of platelet count calculation 
on 30 subjects of DHF research from Shapiro-Wilk 
normality test it was found that the distribution of 
platelet count value was normal, with the mean 
value of platelet count change of 29.547 ± 
45.244.12 /μl. The change of platelet count is ob-
tained from platelet count on day 6/7 heat minus 
platelet count in hot day 4/5. No previous research 
has evaluated platelet count change, the study that 
obtained a mean platelet count of DHF patients on 
the first day of hospital admission 77.250 ± 38.041 
/μl and day 3 was hospitalized 94.150 ± 62.116 /μl 
with mean of platelet count change obtained from 
the average of 3rd day platelet count in hospital 
reduced the mean of platelet count in the first day 
of hospital admission 16.900 /μl (14). The average 
of platelet count in this research was 29.547 /μl 
greater than the average value of platelet count 
change by 16.900 /μl (14).
The average platelet count change in the first 
examination in this study was lower so that when 
the recovery phase occured in the course of dengue 
disease. A larger increase in platelet count was 
measured at the second examination to return to 
normal platelet count value (14). The average of 
platelet count in the first examination in this study 
was lower because of the possibility of the exami-
nation was performed on the heat of the day to 4/5. 
Then, the platelet count of DHF patients tend to be 
low whereas the first platelet count examination 
performed at the time of DHF patients entered the 
hospital the first day that could occur in the heat of 
day to any in the course of dengue disease (14).
The correlation between IPF and platelet count 
change in DHF patients in this study was obtained r = 
0.746 with the p-value of 0.000 (α = 5%). Based on the 
results of statistical calculations concluded that there 
was a correlation between IPF and platelet count 
changes in patients with DHF in Dr. Soetomo General 
Hospital Surabaya. Pearson correlation coefficient 
value (r) of 0.746, suggesting a correlation between 
IPF and platelet count change in DHF patients in Dr. 
Soetomo General Hospital Surabaya was strong. The 
direction of a positive or unidirectional correlation 
means that when IPF increased, the higher the then the 
platelet count changes would also increase. As many 
as 84.3% of patients experienced platelet count eleva-
tion within 24 hours after IPF peak increase it could be 
concluddd that IPF can be used to monitor platelet 
count reconstitution in DHF patients. 120 DHF pa-
tients get if IPF> 6.25% then there is a 67% chance of 
a platelet increase of 20.000 /μl within 48 hours, and if 
IPF> 10.6% there is a 100% chance of a 20.000 /μl 
increase in platelet in 48 hours (15).
The research that has been performed to ana-
lyze the correlation between IPF and platelet count 
in DHF patients who entered the hospital on the 
first day and between IPF and platelet count in 
DHF patients who were hospitalized on day 3 of 
20 dengue fever patients (14). The correlation be-
tween IPF and platelet count in dengue patients 
admitted to hospital on the first day was r = -0.662 
with p = 0.001, and on day 3 admitted hospital r = 
-0.675 with p = 0.001 (14). This study shows that 
the lower the platelet count will be the higher the 
value of IPF at the same time.
In dengue patients with thrombocytopenia con-
ditions, the value of IPF will increase with recov-
ery in the bone marrow that will increase platelet 
count in peripheral blood 1-2 days later. In patients 
with ITP-induced thrombocytopenia where abnor-
malities that occured were platelet destruction in 
peripheral blood circulation caused by an autoim-
mune process and no disturbance in the bone mar-
row, the IPF score will be high since the onset of 
thrombocytopenia. In ITP patients high IPF values 
were not followed by an increase in platelet count 
in peripheral blood circulation in the next 1-2 days 
because the process of platelet destruction in pe-
ripheral blood circulation occured more than plate-
let production from bone marrow.
The results of this study indicated that the research 
samples with IPF value were higher then we get an 
increase in platelet count is also higher. While in the 
sample of research with low IPF value obtained the 
counting of platelet count. The increase or decrease 
in platelet count in line with the occurrence of plasma 
leakage according to the clinical course of DHF pa-
tients. Patients with platelet count changes are still 
decreasing in line with the occurrence of leakage 
plasma is still worsening, while patients with platelet 
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count changes that increase in line with the improved 
plasma leakage. Fluid therapy in dengue patients still 
experiencing worsening plasma leakage should be 
adequate to avoid falling under shock, while fluid 
therapy in dengue fever patients with improved 
plasma leakage should not be overly aggressive and 
should be alert because once plasma leakage im-
proves there will be a shift back fluid to the intravas-
cular and may occur overload when fluid therapy is 
too aggressive. So with the data of IPF on DHF pa-
tients are strongly correlated positively with platelet 
count changes in line with the occurrence of plasma 
leakage it can be used as one of the considerations of 
fluid therapy in patients with DHF..
coNclusioN
There was a strong correlation between IPF 
level and platelet count change in DHF patients. It 
suggested that IPF to be used for monitoring DHF 
due to its ability to early predict platelet count 
changes in the next 1-2 days.
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